Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.

CONCLUSIONS: The largest such study to date (comprising of over 23,000 patients), this investigation demonstrates the survival benefit to ablative radiotherapy for early-stage NSCLC. Maturation of comparative prospective trials is eagerly awaited. PMID: 30031630 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30031630?dopt=Abstract

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - July 18, 2018 Category: Radiology Authors: Haque W, Verma V, Polamraju P, Farach A, Butler EB, Teh BS Tags: Radiother Oncol Source Type: research